Endothelial damage and vascular calcification in patients with chronic kidney disease

Sagrario Soriano1, Andrés Carmona1, Francisco Triviño2

  • 1Instituto Maimónides de Investigación Biomédica de Córdoba, Reina Sofía University Hospital, University of Córdoba, Córdoba, Spain; Nephrology Unit, Reina Sofía University Hospital, Córdoba, Spain; RETICs Red Renal (Instituto de Salud Carlos III), Madrid, Spain; and.

Insights

Vascular calcification in chronic kidney disease is linked to more endothelial microparticles and fewer endothelial progenitor cells. These microparticles may drive calcification by increasing osteocalcin expression in progenitor cells.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Cell Biology

Background:

  • Vascular calcification (VC) is a significant complication in chronic kidney disease (CKD), increasing cardiovascular risks.
  • Endothelial microparticles (MPs) and endothelial progenitor cells (EPCs) are implicated in vascular health and disease.

Purpose of the Study:

  • To investigate the role of endothelial MPs and EPCs in the development of VC in CKD patients.
  • To explore the mechanisms by which MPs and EPCs influence VC, particularly osteocalcin (OCN) expression.

Main Methods:

  • Quantified circulating endothelial MPs and EPCs in CKD patients with and without VC.
  • Assessed OCN expression in EPCs from CKD patients.
  • Conducted in vitro experiments using MPs from CKD patients to induce OCN expression in healthy EPCs, vascular smooth muscle cells, and fibroblasts.

Main Results:

  • CKD patients with VC had significantly higher levels of circulating endothelial MPs and lower percentages of EPCs compared to those without VC.
  • EPCs expressing OCN were more numerous in CKD patients with VC.
  • MPs from CKD patients induced OCN expression in healthy EPCs, vascular smooth muscle cells, and fibroblasts, with a more pronounced effect from MPs of VC patients.

Conclusions:

  • An imbalance between endothelial damage (increased MPs) and repair (decreased EPCs) contributes to VC in CKD.
  • EPCs, via OCN expression, may directly participate in the pathogenesis of vascular calcification in CKD patients.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
4
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
670
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
671
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.1K